Livzon Pharmaceutical Group Inc. | Ownership
Companies that own Livzon Pharmaceutical Group Inc.
Norges Bank Investment Management
7,240,771
2.94%
-492,581
0%
12/31/2017
UBS Asset Management (Hong Kong) Ltd.
4,084,298
1.66%
130,390
0.38%
05/15/2018
The Vanguard Group, Inc.
3,146,469
1.28%
-35,000
0%
07/31/2018
GF Fund Management Co., Ltd.
2,171,390
0.88%
988,390
0.11%
12/31/2017
Value Partners Ltd.
1,716,390
0.7%
-2,667,301
0.11%
12/31/2017
Aviva Investors Global Services Ltd.
1,633,384
0.66%
633,265
0.01%
06/30/2018
Dimensional Fund Advisors LP
1,428,093
0.57%
-22,620
0%
04/30/2018
Grantham, Mayo, Van Otterloo & Co. LLC
1,026,610
0.42%
862,290
0.01%
02/28/2018
China Universal Asset Management Co., Ltd.
1,000,857
0.41%
-273,910
0.04%
12/31/2017
FIL Investment Advisors (UK) Ltd.
773,487
0.31%
773,487
0%
12/31/2017
| Address |
Headquarter Building
Zhuhai Guangdong 519090
China
|
|
Employees
|
- |
| Website |
http://www.livzon.com.cn |
| Updated |
07/08/2019 |
| Livzon Pharmaceutical Group, Inc. engages in the research and development, production, and distribution of pharmaceutical products. It offers drug preparation products, bulk medicines and intermediates, and diagnostic reagents and equipment. The company was founded on March 1, 1992 and is headquartered in Zhuhai, China. |
